|
Market Closed -
Euronext Paris
11:55:00 2026-09-03 EDT
|
After hours 15:59:59 | |||
| 76.27 EUR | -1.15% |
|
76.56 | +0.39% |
| 09-02 | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | RE |
| 09-02 | Sanofi : Gets a Buy rating from Deutsche Bank | ZD |
| Market Cap | 91.38B 106B 85.75B 78.45B 146B 10,039B 148B 1,014B 395B 5,131B 399B 390B 16,524B | P/E 2026 * |
12.3x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 103B 120B 96.5B 88.29B 165B 11,298B 166B 1,142B 445B 5,774B 449B 439B 18,595B | EV / Sales 2026 * |
2.16x | EV / Sales 2027 * | 1.96x |
| Free-Float |
88.34% | Yield 2026 * |
5.51% | Yield 2027 * | 5.83% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
|
Boerse Muenchen
| SNW | Real-time | |
|
Xetra
| SNW | Delayed | |
|
Tradegate
| SNW | Real-time | |
|
Deutsche Boerse AG
| SNW | Delayed | |
|
London S.E.
| 0O59 | Delayed | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
Börse Stuttgart
| SNW | Delayed | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
OTC Markets
| SNYNF | Delayed | |
|
Mexican S.E.
| SAN1 N | End-of-day quote | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
Swiss Exchange
| SAN | Delayed | |
|
CBOE
| 0O59 | Real-time |
Last Transcript : Sanofi
| 1 day | -1.15% | ||
| 1 week | -2.58% | ||
| Current month | -0.70% | ||
| 1 month | +2.42% | ||
| 3 months | +3.88% | ||
| 6 months | -6.36% | ||
| Current year | -7.80% |
| 1 week | 76.25 |  | 78.15 |
| 1 month | 73.63 | | 79.36 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Buy | Executive/Senior Manager | 840 | 0.0001% | ||
| 8/20/26 | Buy | 1,422 | 0.0001% | |||
| 8/20/26 | Buy | Chief Technology Officer | 168 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.15% | -2.58% | -9.75% | -22.65% | 107B | |
| -0.04% | -1.40% | +57.16% | +107.74% | 1,034B | |
| +1.17% | +4.76% | +56.42% | +73.28% | 663B | |
| -0.58% | +0.80% | +22.82% | +78.10% | 462B | |
| +2.09% | -3.20% | +36.07% | +37.41% | 344B | |
| 0.00% | +3.26% | +29.76% | +46.97% | 307B | |
| +1.42% | -0.72% | +2.03% | +13.51% | 251B | |
| +0.29% | +1.63% | +56.46% | +74.84% | 239B | |
| -0.03% | -1.11% | -15.87% | -53.65% | 207B | |
| +1.08% | +1.59% | +33.83% | +101.20% | 186B | |
| Average | +0.46% | -0.77% | +26.89% | +45.68% | 380.05B | |
| Weighted average by Cap. | +0.57% | -0.86% | +38.05% | +65.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.68B 55.42B 44.75B 40.94B 76.41B 5,239B 77.02B 529B 206B 2,677B 208B 204B 8,622B | 50.81B 59.05B 47.68B 43.62B 81.42B 5,582B 82.07B 564B 220B 2,853B 222B 217B 9,188B |
| Net income | 7.91B 9.19B 7.42B 6.79B 12.68B 869B 12.78B 87.82B 34.2B 444B 34.53B 33.77B 1,431B | 9.24B 10.74B 8.67B 7.94B 14.81B 1,016B 14.93B 103B 39.96B 519B 40.34B 39.46B 1,672B |
| Net Debt | 11.46B 13.32B 10.75B 9.84B 18.36B 1,259B 18.51B 127B 49.53B 643B 50B 48.91B 2,072B | 8.3B 9.65B 7.79B 7.13B 13.31B 912B 13.41B 92.18B 35.9B 466B 36.24B 35.45B 1,502B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | €76.27 | -1.15% | 1,808,704 |
| 26-09-02 | €77.16 | +0.39% | 1,244,986 |
| 26-09-01 | €76.86 | +0.07% | 1,718,967 |
| 26-08-31 | €76.81 | -0.57% | 2,863,251 |
| 26-08-28 | €77.25 | -0.04% | 1,056,025 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
